Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-033014
Filing Date
2024-08-19
Accepted
2024-08-19 10:08:29
Documents
44
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 675481
2 ex31-1.htm EX-31.1 18023
3 ex31-2.htm EX-31.2 18101
4 ex32-1.htm EX-32.1 6862
5 ex32-2.htm EX-32.2 6719
  Complete submission text file 0001493152-24-033014.txt   3042084

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE btax-20240331.xsd EX-101.SCH 22597
7 XBRL CALCULATION FILE btax-20240331_cal.xml EX-101.CAL 29064
8 XBRL DEFINITION FILE btax-20240331_def.xml EX-101.DEF 53583
9 XBRL LABEL FILE btax-20240331_lab.xml EX-101.LAB 183881
10 XBRL PRESENTATION FILE btax-20240331_pre.xml EX-101.PRE 133866
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 429645
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54933 | Film No.: 241218595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)